New drug delivery system developed to prevent immune activation

The Platform trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity and safety of seven licensed COVID-19 vaccines delivered as fifth dose or subsequent boosters in immunocompetent adults.

Vaccine·2026

The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old.

The Journal of infection·2024

Core protocol for the adaptive Platform Trial In COVID-19 Vaccine priming and BOOsting (PICOBOO).

Trials·2023

Osteoarthritis consumers as co-researchers: identifying consumer insights to improve osteoarthritis management by co-designing translational research solutions.

Osteoarthritis and cartilage·2023

DNA methylation is associated with codon degeneracy in a species of bumblebee.

Heredity·2023

Evaluation of Pirfenidone and Nintedanib in a Human Lung Model of Fibrogenesis.

Frontiers in pharmacology·2021

CARM1: an epigenetic brake on cDC1-mediated antitumor immunity.

Trends in immunology·2026

Neurons as cytokine sensors in the central nervous system.

Trends in immunology·2026

Breast milk IgG: 'it does a baby good'.

Trends in immunology·2026

Mitochondrial Complex II in the regulation of immunopathology.

Trends in immunology·2026

Exercise-driven microbiome changes regulate host immunity.

Trends in immunology·2026

One lipid to imprint them all?

Trends in immunology·2026

Myotonic dystrophy type 1 - updates on mechanisms of multisystemic manifestations, genetically targeted therapeutics, and preparing for a postapproval world.

Current opinion in neurology·2026

Immunotherapeutic efficacy of transdermal delivery of anti-CD3 antibody-conjugated magnetic nanoparticles using a hyaluronic acid-based dissolving microneedle patch.

Drug delivery and translational research·2026

Related Experiment Videos

New drug delivery system developed to prevent immune activation

Related Concept Videos

The Platform trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity and safety of seven licensed COVID-19 vaccines delivered as fifth dose or subsequent boosters in immunocompetent adults.

The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old.

Core protocol for the adaptive Platform Trial In COVID-19 Vaccine priming and BOOsting (PICOBOO).

Osteoarthritis consumers as co-researchers: identifying consumer insights to improve osteoarthritis management by co-designing translational research solutions.

DNA methylation is associated with codon degeneracy in a species of bumblebee.

Evaluation of Pirfenidone and Nintedanib in a Human Lung Model of Fibrogenesis.

CARM1: an epigenetic brake on cDC1-mediated antitumor immunity.

Neurons as cytokine sensors in the central nervous system.

Breast milk IgG: 'it does a baby good'.

Mitochondrial Complex II in the regulation of immunopathology.

Exercise-driven microbiome changes regulate host immunity.

One lipid to imprint them all?

Myotonic dystrophy type 1 - updates on mechanisms of multisystemic manifestations, genetically targeted therapeutics, and preparing for a postapproval world.

Immunotherapeutic efficacy of transdermal delivery of anti-CD3 antibody-conjugated magnetic nanoparticles using a hyaluronic acid-based dissolving microneedle patch.

Related Experiment Videos

New drug delivery system developed to prevent immune activation

Related Concept Videos

Related Articles